Le Lézard
Classified in: Health, Science and technology
Subject: PDT

FDA Clears nView Medical's First Imaging System, nView s1


SALT LAKE CITY, July 13, 2019 /PRNewswire-PRWeb/ -- nView medical Inc. (nView) today announced the U.S. Food and Drug Administration (FDA) clearance of nView s1, the company's first imaging system, bringing breakthrough imaging technology to surgery.

nView's mission is to make surgery safer, faster, and consistently accurate by creating instant 3D information throughout the surgical procedure. nView s1 integrates the latest developments in low-dose x-ray imaging with intelligent imaging algorithms to provide fluoroscopic and multiplanar views derived from tomographic reconstructions. These views can be used by surgeons to accurately assess the anatomy and placement of implants during spinal and orthopedic procedures.

"nView s1 is an imaging platform that provides invaluable information to surgeons throughout the procedure. The technology can be used intraoperatively to visualize the surgery and at the end of the procedure to confirm the quality of the surgery. The future of surgery will be enabled by automation and quantification. nView s1 is our first step in that direction" said Cristian Atria, founder and CEO at nView medical.

Lisa Last, COO, commented: "nView s1 has been cleared as a fluoroscopic and tomographic imaging system for adult and pediatric populations. In pediatrics, our low-dose operation brings a unique opportunity to increase precision via 3D imaging while minimizing radiation exposure. The 510(k) clearance will allow us to expand our work with research partners in pilot sites".

About nView
nView medical, based in Salt Lake City, UT, is an early stage start-up whose mission is to make surgery safer, faster, and consistently accurate. nView develops imaging systems, bringing breakthrough AI solutions for image creation, image processing, and image visualization to surgery. nView medical backers include the National Science Foundation (NSF), the National Institutes of Health (NIH), the State Of Utah, the National Consortium for Pediatric Device Innovation, MedtechInnovator, Dr. Kevin Foley, MD, and Fusion Fund (Palo Alto, CA).

 

SOURCE nView medical


These press releases may also interest you

at 19:00
Innovative technology company, DOOGEE Hengtong Technology Co. Ltd., is today pleased to announce the launch of its latest phone, the DOOGEE S88 Pro. The DOOGEE S88 Pro is a rugged smartphone that is packed full of features including a 10,000 mAh...

at 17:00
Glenn Thomas, founder and principal of Pathway Capital Corporation, which specializes in funding solutions for complex transactions, announced that Robert Capalbo has joined his company's team of specialty finance professionals. A seasoned commercial...

at 13:00
Brander Group Inc. joins the strategic affiliate partnership program with INDATEL. Their group members part have relied on Brander Group to buy IP address blocks across the United States for the past few years. As local regional internet services...

at 11:00
Advanced Software Products Group (ASPG, Inc.) is pleased to announce the latest release of MegaCryption 6.5.0. Specifically designed for z/OS environments, MegaCryption is a comprehensive enterprise and mainframe cryptography toolkit providing...

at 08:30
AbbVie , a research-based global biopharmaceutical company, today announced new Phase 3 data from the SELECT-CHOICE clinical trial, showing that RINVOQtm (upadacitinib, 15 mg, once daily) met the primary endpoint of non-inferiority versus ORENCIA®...

at 06:45
Genetron Holdings Limited ("Genetron Health"), a China-based precision oncology company that covers full-cycle cancer care, announced that its independently developed detection kit for the novel coronavirus (Genetron SARS-CoV-2 RNA Test) received...



News published on 13 july 2019 at 16:00 and distributed by: